ChromaDex Expands Patent Rights to Pterostilbene IRVINE,

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
ChromaDex Expands Patent Rights to Pterostilbene

IRVINE, Calif., June 4, 2015 (GLOBE NEWSWIRE) -- ChromaDex Corp. (OTCQX: CDXC ), an innovative natural products company that provides proprietary ingredients and science-based solutions to the dietary supplement, food and beverage, cosmetic and pharmaceutical industries, announced today it has added to its list of exclusive patents rights related to pterostilbene licensed from the University of Mississippi. The newly licensed patent relates to potential anti-obesity effects of pterostilbene.

ChromaDex's branded nature identical pterostilbene, pTeroPure ® , is an anti-oxidant found in berries and nuts. It was named the 2010 North American Most Promising Ingredient of the Year by the independent research company Frost & Sullivan. Pterostilbene belongs to a group of compounds called stilbenoids, which are produced by plants as part of their natural defense systems. ChromaDex launched pTeroPure ® in 2010 and today, more than 40 consumer products containing pTeroPure ® are available in the marketplace.

The license covers U.S. Patent Application Serial No. 13/463,442 and corresponding Patent Cooperation Treaty (PCT), which was filed May 3, 2012 by the U.S. Department of Agriculture (USDA), entitled "Anti-Obesity Effect of Pterostilbene," invented by Agnes Rimando and Maria del Puy Portillo and jointly owned by the USDA and the Universidad del Pais Vasco/Euskal Herriko Unibertsitatea (University of Basque Country). USDA's Agricultural Research Service (ARS) and University of Basque Country's patent rights have been exclusively licensed to the University of Mississippi.

"ChromaDex continues to be a valued partner of the University of Mississippi and the relationship is a prime example of how academic research can promote economic development," said Walt Chambliss, UM director of technology management. "ChromaDex knows the value of our research, and that's the key ingredient in a partnership like this," Chambliss said.

Frank Jaksch, CEO and co-founder of ChromaDex, commented, "ChromaDex has been successfully commercializing pterostilbene under the trade name pTeroPure ® since we first licensed the exclusive rights to the compound from the University of Mississippi in 2010. We now have exclusive worldwide rights on five patents and several patent applications relating to pterostilbene."

A rat study conducted by researchers at The University of Basque Country's (UDV/EHU) nutrition and obesity group in collaboration with the USDA was published in October 2014 in the Journal of Agricultural and Food Chemistry.

In 2010, ChromaDex announced an exclusive worldwide license for two different pterostilbene patents from the University of Mississippi and the USDA ARS. In April 2014, a collaboration consisting of the University of Mississippi's Division of Technology Management, USDA-ARS's Natural Products Utilization Research Unit and ChromaDex won a Federal Laboratory Consortium 2014 Excellence in Technology Transfer Award  for their work developing pterostilbene.

About the University of Mississippi:

The University of Mississippi, the flagship University for the State of Mississippi, opened in 1848. It offers nationally recognized programs across a broad range of undergraduate and graduate studies, from medicine and law to creative writing and accountancy. With more than 23,000 students, Ole Miss is the state's largest university, and the Chronicle of Higher Education named it as the nation's 13th-fastest growing university in its Almanac of Higher Education 2014. The university has a diverse student body (23.8 percent of students are ethnic minorities) representing all 50 states and 92 countries. It has been ranked as one of America's best college values by Kiplinger's Personal Finance and one of the best places to work by the Chronicle of Higher Education.

The USDA-ARS Natural Products Utilization Research Unit focuses on discovery of natural product-based pest management solutions and research in support of minor and new crops.

About ChromaDex:

ChromaDex is an innovative natural products company that discovers, acquires, develops and commercializes proprietary-based ingredient technologies through its unique business model that utilizes its wholly owned synergistic business units, including ingredient technologies, natural product fine chemicals (known as "phytochemicals"), chemistry and analytical testing services, and product regulatory and safety consulting (as Spherix Consulting). The company provides seamless science-based solutions to the nutritional supplement, food and beverage, animal health, cosmetic and pharmaceutical industries. The ChromaDex ingredient technologies unit includes products backed with extensive scientific research and intellectual property. Its ingredient portfolio includes pTeroPure ® pterostilbene; ProC3G ® , a natural black rice containing cyanidin-3-glucoside; PURENERGY ® , a caffeine-pTeroPure ® co-crystal; and NIAGEN ® , its recently launched branded nicotinamide riboside, a novel next-generation B vitamin. To learn more about ChromaDex, visit www.chromadex.com .

Forward-Looking Statements:

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities and Exchange Act of 1934, as amended. Statements that are not a description of historical facts constitute forward-looking statements and may often, but not always, be identified by the use of such words as "expects", "anticipates", "intends", "estimates", "plans", "potential", "possible", "probable", "believes", "seeks", "may", "will", "should", "could" or the negative of such terms or other similar expressions. Actual results may differ materially from those set forth in this release due to the risks and uncertainties inherent in the Company's business. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company's Annual Report on Form 10-K for the fiscal year ended January 3, 2015, the Company's Quarter Reports on Form 10-Q and other filings submitted by the Company to the SEC, copies of which may be obtained from the SEC's website at www.sec.gov . Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement and the Company undertakes no obligation to revise or update this release to reflect events or circumstances after the date hereof.

ChromaDex Investor Contacts: The Del Mar Consulting Group, Inc. Robert B. Prag, President 858-794-9500 ChromaDex Company Contact: Andrew Johnson, Director of Investor Relations 949-419-0288

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Vail Resorts Bets on Music to Deepen Epic Pass Demand

Updated Category News Views 119

A bass drop at 11,000 feet is not merely a party trick when you run 42 mountain resorts. Vail Resorts is putting live music, après programming and destination events squarely beside skiing and riding for winter 2026-27, and the business logic is pretty plain: give people another reason to buy early, stay longer and return with friends. For investors watching MTN, this is...

Continue Reading
NYSE Message Record Puts Market Plumbing Into Focus

Updated Category News Views 120

A trillion messages is not a cute little exchange statistic; it is the sort of number that tells you whether the market’s pipes can keep working when everybody starts shouting at once. NYSE says it handled a record 1.166 trillion messages in one day on November 5, roughly 4% above the prior high set amid April 2025 volatility. Better yet, according to the exchange,...

Continue Reading
LGT Middle East Win Highlights Patient Private Banking

Updated Category News Views 166

A trophy in Dubai is not a balance sheet, but it can be a useful calling card when the clientele measures relationships in decades rather than quarters. LGT Middle East was named Best Pure Play Private Bank at the WealthBriefing MENA Awards 2026, at a ceremony held in Dubai on November 18. For a family-owned wealth manager working with Middle Eastern families, that sort...

Continue Reading
Holland America Puts 2028 Alaska Demand on Display

Updated Category News Views 123

Alaska’s interior is where a cruise brochure either earns its keep or gets exposed. Holland America Line is opening bookings for 2028 Alaska Cruisetours nearly two years ahead, tying a coast-and-land product to the reimagined Oosterdam’s Alaska debut. That is not merely another itinerary release. It is a fairly deliberate attempt to sell a bigger, longer and...

Continue Reading
New York's $1.2M Prison Abuse Deal Raises State Stakes

Updated Category News Views 30

One courtroom result can expose a whole warehouse of institutional neglect, and this one lands with a grim thud. New York has agreed to pay $1.2 million to resolve a claim involving sexual assault by a former corrections officer at Bayview Correctional Facility in Manhattan. The settlement came after a two-week Adult Survivors Act bellwether trial concluded on November 17...

Continue Reading
Africa’s Digital Leap Still Has a 64% Usage Problem

Updated Category News Views 100

A continent can be blanketed in signal and still feel digitally stranded. That is the stubborn fact sitting inside the GSMA Digital Africa Index 2026: mobile broadband reaches 92% of Africa’s population, while only 28% use mobile internet on their own devices. The 64% usage gap is not a rounding error or a tidy policy footnote. It is the whole unfinished job. From an...

Continue Reading
SciBase Sets Its 2027 AGM Nominating Committee Early

Updated Category News Views 94

Four names on a committee roster rarely make anyone pound the table, and they should not. Still, SciBase Holding has put an important bit of corporate housekeeping in place for its 2027 Annual General Meeting: the nominating committee that will handle shareholder-facing governance work ahead of the May 20 meeting in Stockholm. For a small listed medical-technology...

Continue Reading
Ajman Forum Puts Trust at the Center of Crisis Media

Updated Category News Views 82

Rumours do not wait politely for a communications team to finish its meeting. That plain reality sat underneath Abdulla bin Mohammed bin Butti Al Hamed's keynote at Ajman Media Forum 2026, and it is a tougher point than the usual talk about reach, engagement, or flashy new technology. In a crisis, an information vacuum gets filled fast, usually by somebody with no...

Continue Reading
RUDSAK Tests Premium Demand From Toronto to New York

Updated Category News Views 145

A coat rack on Bloor Street can tell a harsher story than a glossy expansion announcement. RUDSAK has opened a Toronto flagship at 55 Bloor Street West in the Manulife Centre and is preparing a boutique at American Dream outside New York City. This is a real step up in retail ambition for the Montréal luxury outerwear house, founded in 1994, and it deserves more than the...

Continue Reading
Shenzhen Three-Way Summit Puts Stability to the Test

Updated Category News Views 153

Three nuclear powers sharing a room in Shenzhen is the sort of headline that makes every risk desk sit upright, even when the paperwork remains thin. CGTN reports that Chinese President Xi Jinping, Russian President Vladimir Putin and U.S. President Donald Trump met on November 19, 2026, in an unprecedented trilateral summit and issued a Declaration toward Peace. That is...

Continue Reading

Top 5 Most Recently Viewed Articles

OmniPathology Partners with Gestalt to Enhance Diagnostic Equity

Updated Category News Views 159

OmniPathology Joins Forces with Gestalt for a Digital Revolution In an exciting development for the medical field, OmniPathology has chosen Gestalt as its strategic partner to innovate their digital pathology solutions. This collaboration signifies a step towards modernizing diagnostic workflows, ultimately enhancing the quality of healthcare services. Transforming...

Continue Reading
Kneat Partners with Leading Global Therapeutics Firm

Updated Category News Views 232

Kneat Partners with Leading Global Therapeutics Firm Kneat.com, inc. (TSX: KSI) (OTCQX: KSIOF), known for its expertise in digitizing and automating essential validation and quality processes, has secured a significant three-year Master Services Agreement with a prominent global therapeutics company. This collaboration aims to fully digitize the validation processes of...

Continue Reading
Exploring Dividend Opportunities with Pfizer and Bristol Myers Squibb

Updated Category News Views 84

The Current State of Dividend Stocks The past year has been quite eventful for stock markets, showcasing significant gains across various indices. However, this surge has made it more difficult for investors to find stocks that are reasonably priced. With the S&P 500 index seeing a substantial increase, identifying attractive buying opportunities has become a challenge...

Continue Reading
Magna International's Impressive Quarterly Progress and Future Outlook

Updated Category News Views 403

Overview of Magna International's Second Quarter Results Magna International Inc. reported robust performance for the second quarter of 2025, showcasing resilience in the face of industry challenges. The company achieved $10.6 billion in sales, despite a 3% decline compared to the previous year, attributed mainly to lower light vehicle production in various markets....

Continue Reading
Guardian Capital Unveils Projected Non-Cash Distributions for ETFs

Updated Category News Views 265

Guardian Capital Announces Estimated 2025 Distributions Guardian Capital LP is pleased to share its estimated annual non-cash year-end distributions for the 2025 tax year related to the Guardian Capital ETFs. Please note that these estimates were made as of mid-November, and while they provide valuable insight, the final amounts may change before the tax year-end in late...

Continue Reading